about
Structure of a low-melting-temperature anti-cholera toxin: llama VHH domainOxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyRapid method for isolation of desiccation-tolerant strains and xeroprotectantsEffects of glycosylation on the stability of protein pharmaceuticals.Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.Effects of shear on proteins in solution.Quality assessment and optimization of purified protein samples: why and how?Effect of Nonionic Surfactants (Dodecyl Maltoside and Polysorbate 20) on Prevention of Aggregation and Conformational Changes of Recombinant Human IFNβ_1b Induced by Light.The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.Application of hanging drop technique to optimize human IgG formulations.
P2860
Q27676164-8C875351-1E81-498C-B128-40177B475822Q30402355-6EA2A846-81B6-4D56-9F86-99E431E653F9Q33368131-3686F2D2-4059-4179-8CD7-27E12A41856FQ33586660-CED5192B-DE36-4C27-AB33-9089D8389FA6Q33609537-13BCA3AE-36A6-4E58-B76C-524671C617ACQ37114305-8BF78C8E-9DF2-49B9-B7D8-6CF408CC459DQ37579215-2FD48AFC-A5FD-4D92-ACB6-1E4907F5BC7BQ37810518-D9876ACF-DC4F-4982-B8D5-6C60ACF74FDBQ38303016-5B4E0D3F-BE23-469E-877C-D09CE84E6A64Q38790737-599AD7DD-D0AA-4A92-8FD2-D83009EF6B32Q41907182-E952095D-B0EB-431C-90B1-74B47C22CF3AQ42932514-E1FFECBB-2B08-4F37-9267-85DDE0029E02
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Protein formulation and fill-finish operations.
@ast
Protein formulation and fill-finish operations.
@en
type
label
Protein formulation and fill-finish operations.
@ast
Protein formulation and fill-finish operations.
@en
prefLabel
Protein formulation and fill-finish operations.
@ast
Protein formulation and fill-finish operations.
@en
P2093
P1476
Protein formulation and fill-finish operations.
@en
P2093
Byeong S Chang
Erwin Freund
Sugunakar Y Patro
P356
10.1016/S1387-2656(02)08004-3
P577
2002-01-01T00:00:00Z